Search research articles
Contact Us
Filters
Showing results (101-110 of 443) with videos related to
Page
of 45
Sort By:
Lancet (London, England)
|
August 27, 2023
New Zealand's COVID-19 elimination strategy and mortality patterns
Stacey Kung, Thomas Hills, Nethmi Kearns, et al.
Lancet (London, England)
|
November 24, 2020
Influenza control during the COVID-19 pandemic
Thomas Hills, Nethmi Kearns, Ciléin Kearns, et al.
Thorax
|
November 12, 2013
Letter in response to Tashkin et al: Limited generalisability of uplift findings to clinical practice
Steven Walker, James Fingleton, Mark Weatherall, et al.
The American Journal of Medicine
|
May 26, 2007
Balancing the risks and benefits of celecoxib
Brent Caldwell, Richard Beasley, Mark Weatherall, et al.
The New Zealand Medical Journal
|
November 29, 2005
Increased risk of cardiovascular events with parecoxib/valdecoxib: a systematic review and meta-analysis
Sarah Aldington, Philippa Shirtcliffe, Mark Weatherall, et al.
Clinical Medicine (London, England)
|
July 16, 2008
The New Zealand national junior doctors' strike: implications for the provision of acute hospital medical services
Geoffrey Robinson, Kieran McCann, Peter Freeman, et al.
Journal of the Royal Society of Medicine
|
May 24, 2012
Proposed MHRA changes to UK children's paracetamol dosing recommendations: modelling study
Sally Eyers, James Fingleton, Kyle Perrin, et al.
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine
|
September 2, 2011
A systematic review of the accuracy of peripheral thermometry in estimating core temperatures among febrile critically ill patients
Sarah Jefferies, Mark Weatherall, Paul Young, et al.
The New Zealand Medical Journal
|
June 7, 2005
Raised plasma homocysteine levels in alcoholism: increasing the risk of heart disease and dementia?
Geoffrey Robinson, Seshasayee Narasimhan, Mark Weatherall, et al.
Translational Respiratory Medicine
|
May 29, 2016
A half doubling dose change in bronchial hyperresponsiveness in a population represents an important difference
Mark Weatherall, James Fingleton, Sally Eyers, et al.
Page
of 45
Search research articles
Search
Showing results (101-110 of 443) with videos related to
Sort By:
Page
of 45
Lancet (London, England)
|
August 27, 2023
New Zealand's COVID-19 elimination strategy and mortality patterns
Stacey Kung, Thomas Hills, Nethmi Kearns, et al.
Lancet (London, England)
|
November 24, 2020
Influenza control during the COVID-19 pandemic
Thomas Hills, Nethmi Kearns, Ciléin Kearns, et al.
Thorax
|
November 12, 2013
Letter in response to Tashkin et al: Limited generalisability of uplift findings to clinical practice
Steven Walker, James Fingleton, Mark Weatherall, et al.
The American Journal of Medicine
|
May 26, 2007
Balancing the risks and benefits of celecoxib
Brent Caldwell, Richard Beasley, Mark Weatherall, et al.
The New Zealand Medical Journal
|
November 29, 2005
Increased risk of cardiovascular events with parecoxib/valdecoxib: a systematic review and meta-analysis
Sarah Aldington, Philippa Shirtcliffe, Mark Weatherall, et al.
Clinical Medicine (London, England)
|
July 16, 2008
The New Zealand national junior doctors' strike: implications for the provision of acute hospital medical services
Geoffrey Robinson, Kieran McCann, Peter Freeman, et al.
Journal of the Royal Society of Medicine
|
May 24, 2012
Proposed MHRA changes to UK children's paracetamol dosing recommendations: modelling study
Sally Eyers, James Fingleton, Kyle Perrin, et al.
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine
|
September 2, 2011
A systematic review of the accuracy of peripheral thermometry in estimating core temperatures among febrile critically ill patients
Sarah Jefferies, Mark Weatherall, Paul Young, et al.
The New Zealand Medical Journal
|
June 7, 2005
Raised plasma homocysteine levels in alcoholism: increasing the risk of heart disease and dementia?
Geoffrey Robinson, Seshasayee Narasimhan, Mark Weatherall, et al.
Translational Respiratory Medicine
|
May 29, 2016
A half doubling dose change in bronchial hyperresponsiveness in a population represents an important difference
Mark Weatherall, James Fingleton, Sally Eyers, et al.
Page
of 45